Pediatric bacterial meningitis and meningococcal disease profile in a Brazilian General Hospital
Carregando...
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER BRAZIL
Citação
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, v.24, n.4, p.337-342, 2020
Resumo
Objective: To evaluate the clinical and epidemiological profile of bacterial meningitis and meningococcal disease in pediatric patients admitted to a Brazilian Secondary Public Hospital. Methods: A descriptive observational study was conducted. Microbiologically proven bacterial meningitis or meningococcal disease diagnosed from 2008 to 2018 were included. Results: A total of 90 patients were diagnosed with proven bacterial meningitis. There were 64 confirmed cases of meningococcal disease. The prevalence was higher in boys (n=38), median age 30 months (1-185). The main clinical manifestations were: meningococcal meningitis (n = 27), meningococcemia without meningitis (n = 14), association of meningococcemia with meningitis (n=13), and fever without a known source in infants (n = 7). Admissions to intensive care unit were necessary for 45 patients. Three deaths were notified. Serogroup C was the most prevalent (n = 32) followed by serogroup B (n = 12). Pneumococcal meningitis was identified in 21 cases; out of the total, 10 were younger than two years. The identified serotypes were: 18C, 6B, 15A, 28, 7F, 12F, 15C, 19A and 14. Pneumococcal conjugate 10-valent vaccine covered four of the nine identified serotypes. Haemophilus influenzae meningitis serotype IIa was identified in three patients, median age 4 months (4-7). All of them needed intensive care. No deaths were notified. Conclusion: Morbidity and mortality rates from bacterial meningitis and meningococcal disease remain high, requiring hospitalization and leading to sequelae. Our study observed a reduced incidence of bacterial disease over the last decade, possibly reflecting the impact of vaccination. (C) 2020 Sociedade Brasileira de Infectologia.
Palavras-chave
Meningitis, pneumococcal, Meningitis, meningococcal, Meningitis, Haemophilus, Meningitis, bacterial, Vaccines, Brazil
Referências
- Aguilar J, 2010, MEDICINE, V89, P117, DOI 10.1097/MD.0b013e3181d5453d
- Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210
- Azevedo LC, 2013, PLOS ONE, V8, DOI 10.1371/journaltone.0064524.
- Beall BW, 2011, J INFECT DIS, V203, P1360, DOI 10.1093/infdis/jir052
- Bierrenbach AL, 2018, HUM VACC IMMUNOTHER, V14, P1138, DOI 10.1080/21645515.2017.1391431
- Brouwer MC, 2018, CURR OPIN INFECT DIS, V31, P78, DOI 10.1097/QCO.0000000000000417
- Burgos J, 2014, EUR RESPIR J, V43, P545, DOI 10.1183/09031936.00050413
- Busetti M, 2013, NEW MICROBIOL, V36, P419
- Cardoso MP, 2013, EINSTEIN-SAO PAULO, V11, P521, DOI 10.1590/S1679-45082013000400020
- Davis SM, 2013, VACCINE, V32, P133, DOI 10.1016/j.vaccine.2013.05.005
- Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517
- GBD, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X
- Kmetzsch Claudete I., 2003, J. Pediatr. (Rio J.), V79, P530, DOI 10.1590/S0021-75572003000600012
- Ministry of Health Brazil, 2018, MIN SAUD QUER VAC 10
- Salgado MM, 2013, ARQ NEURO-PSIQUIAT, V71, P672, DOI 10.1590/0004-282X20130148
- Sociedade Brasileira de Pediatria, 2019, IMM PROGR
- Swanson D, 2015, PEDIATR REV, V36, P514, DOI 10.1542/pir.36-12-514
- Zanella RC, 2011, VACCINE, V29, P8937, DOI 10.1016/j.vaccine.2011.09.053